Endava is trading at $2.79, down -5.10%, with no credible company-specific explanation found for the decline.
- No credible September 18, 2026 company-specific announcement, earnings release, or analyst action was found.
- The move diverges from the broader technology sector, which is up 1.56%; major indexes are mixed.
- Earlier JPMorgan and Guggenheim downgrades cited execution concerns and weak demand, but those May actions are stale and do not clearly explain today’s drop.